APA (7th ed.) Citation

Peters, M., van Son, M., Rasing, M., Lagendijk, J., Moerland, M., van de Pol, S., . . . van der Voort van Zyp, J. (2021). PO-1373 Targeted biopsies are redundant in mp-MRI and PSMA-PET proven radiorecurrent prostate cancer. Radiotherapy & Oncology, 161, S1124. https://doi.org/10.1016/S0167-8140(21)07824-5

Chicago Style (17th ed.) Citation

Peters, M., et al. "PO-1373 Targeted Biopsies Are Redundant in Mp-MRI and PSMA-PET Proven Radiorecurrent Prostate Cancer." Radiotherapy & Oncology 161 (2021): S1124. https://doi.org/10.1016/S0167-8140(21)07824-5.

MLA (9th ed.) Citation

Peters, M., et al. "PO-1373 Targeted Biopsies Are Redundant in Mp-MRI and PSMA-PET Proven Radiorecurrent Prostate Cancer." Radiotherapy & Oncology, vol. 161, 2021, p. S1124, https://doi.org/10.1016/S0167-8140(21)07824-5.